EBITDA CAGR uses clean operating EBITDA derived from reported operating income plus depreciation and amortization.
Over longer horizons, EBITDA CAGR averages 44.42% over 3 years; the trailing 12 months came in at +22.42%. EBITDA CAGR shows how the company's operating profitability has grown before depreciation and amortization. This reflects the growth of the core business's cash-operating earnings power, independent of capital-intensity and accounting depreciation choices.
Legence Corp. Class A Common stock (LGN)
EBITDA growth vs the same fiscal quarter in the prior fiscal year, last 2 comparable quarters.
Reported quarterly EBITDA; no daily interpolation. Q2 FY2026 (2026-06-30): $78.86M.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A Quote observation: 2026-10-05T10:50:35.502Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-02.
| Year | Start EBITDA | End EBITDA | Change | % Change |
|---|---|---|---|---|
| 2025 | $169.29M | $207.22M | +$37.93M | +22.41% |
| 2024 | $103.06M | $169.29M | +$66.23M | +64.26% |
| 2023 | $68.77M | $103.06M | +$34.29M | +49.86% |
| Period | Period End | Value | QoQ Growth | YoY Growth |
|---|---|---|---|---|
| Q2 FY2026 | 2026-06-30 | $78.86M | +12.6% | +32.2% |
| Q1 FY2026 | 2026-03-31 | $70.06M | +91.4% | +54.0% |
| Q4 FY2025 | 2025-12-31 | $36.61M | -44.1% | N/A |
| Q3 FY2025 | 2025-09-30 | $65.48M | +9.8% | N/A |
| Q2 FY2025 | 2025-06-30 | $59.63M | +31.0% | N/A |
| Q1 FY2025 | 2025-03-31 | $45.50M | N/A |
| N/A |
| Q2 FY2024 | 2024-06-30 | $57.59M | +76.9% | N/A |
| Q1 FY2024 | 2024-03-31 | $32.55M | N/A | N/A |
QoQ Growth compares the previous fiscal quarter; YoY Growth compares the same fiscal quarter in the prior fiscal year. Missing or ambiguous fiscal periods render N/A.
